PQ 868
868. Deputy Clare Daly asked the Minister for Health further to Parliamentary Questions Nos. 609 to 611, inclusive, of 11 April 2017, the reason he has stated that there was more vaccine produced by a company (details supplied) purchased than that of another company; and the reason 90% of the swine flu vaccinations were of the Pandemrix vaccine as distinct from Celvapan. [19460/17]
Introduced
2 May 2017
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
2 May 2017
Summary
868. Deputy Clare Daly asked the Minister for Health further to Parliamentary Questions Nos. 609 to 611, inclusive, of 11 April 2017, the reason he has stated that there was more vaccine produced by a company (details supplied) purchased than that of another company; and the reason 90% of the swine flu vaccinations were of the Pandemrix vaccine as distinct from Celvapan. [19460/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Vaccination Programme Data
Vaccination Programme Data
xml · EN · 2 May 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-05-02/868/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-05-02/pq_868